TWD 71.9
(-0.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.59 Billion TWD | -0.26% |
2022 | 1.6 Billion TWD | -2.29% |
2021 | 1.63 Billion TWD | 12.97% |
2020 | 1.45 Billion TWD | 16.35% |
2019 | 1.24 Billion TWD | -3.31% |
2018 | 1.28 Billion TWD | 41.24% |
2017 | 913.28 Million TWD | -2.05% |
2016 | 932.43 Million TWD | -16.19% |
2015 | 1.11 Billion TWD | 16.2% |
2014 | 957.48 Million TWD | 40.94% |
2013 | 679.37 Million TWD | -2.58% |
2012 | 697.35 Million TWD | 19.63% |
2011 | 582.91 Million TWD | 24.28% |
2010 | 469.04 Million TWD | 0.0% |
2009 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.78 Billion TWD | 5.51% |
2024 Q1 | 1.68 Billion TWD | 5.77% |
2023 FY | 1.59 Billion TWD | -0.26% |
2023 Q4 | 1.59 Billion TWD | -3.73% |
2023 Q3 | 1.65 Billion TWD | -4.37% |
2023 Q2 | 1.73 Billion TWD | 7.75% |
2023 Q1 | 1.61 Billion TWD | 0.54% |
2022 Q1 | 1.6 Billion TWD | -2.28% |
2022 Q4 | 1.6 Billion TWD | 2.64% |
2022 Q2 | 1.64 Billion TWD | 2.86% |
2022 FY | 1.6 Billion TWD | -2.29% |
2022 Q3 | 1.56 Billion TWD | -5.28% |
2021 Q1 | 1.51 Billion TWD | 4.31% |
2021 Q2 | 1.55 Billion TWD | 2.87% |
2021 FY | 1.63 Billion TWD | 12.97% |
2021 Q3 | 1.59 Billion TWD | 2.48% |
2021 Q4 | 1.63 Billion TWD | 2.73% |
2020 FY | 1.45 Billion TWD | 16.35% |
2020 Q1 | 1.31 Billion TWD | 5.42% |
2020 Q3 | 1.37 Billion TWD | -2.06% |
2020 Q4 | 1.45 Billion TWD | 5.19% |
2020 Q2 | 1.4 Billion TWD | 7.13% |
2019 FY | 1.24 Billion TWD | -3.31% |
2019 Q4 | 1.24 Billion TWD | -2.0% |
2019 Q3 | 1.27 Billion TWD | 1.08% |
2019 Q2 | 1.25 Billion TWD | 0.62% |
2019 Q1 | 1.25 Billion TWD | -3.0% |
2018 Q3 | 1.12 Billion TWD | 1.7% |
2018 Q2 | 1.1 Billion TWD | 5.87% |
2018 Q1 | 1.04 Billion TWD | 14.12% |
2018 FY | 1.28 Billion TWD | 41.24% |
2018 Q4 | 1.28 Billion TWD | 14.95% |
2017 Q1 | 1 Billion TWD | 8.21% |
2017 Q4 | 913.28 Million TWD | -3.82% |
2017 Q3 | 949.6 Million TWD | -6.74% |
2017 Q2 | 1.01 Billion TWD | 0.92% |
2017 FY | 913.28 Million TWD | -2.05% |
2016 Q1 | 1.12 Billion TWD | 1.4% |
2016 Q4 | 932.43 Million TWD | -1.46% |
2016 Q2 | 1.06 Billion TWD | -5.6% |
2016 FY | 932.43 Million TWD | -16.19% |
2016 Q3 | 946.29 Million TWD | -11.15% |
2015 Q3 | 1.06 Billion TWD | -2.35% |
2015 FY | 1.11 Billion TWD | 16.2% |
2015 Q4 | 1.11 Billion TWD | 4.66% |
2015 Q2 | 1.08 Billion TWD | 6.79% |
2015 Q1 | 1.01 Billion TWD | 6.46% |
2014 Q2 | 827.96 Million TWD | 11.68% |
2014 Q1 | 741.38 Million TWD | 9.13% |
2014 Q4 | 957.48 Million TWD | 2.86% |
2014 FY | 957.48 Million TWD | 40.94% |
2014 Q3 | 930.83 Million TWD | 12.43% |
2013 Q1 | 726.39 Million TWD | 4.16% |
2013 Q2 | 691.94 Million TWD | -4.74% |
2013 Q3 | 672.52 Million TWD | -2.81% |
2013 Q4 | 679.37 Million TWD | 1.02% |
2013 FY | 679.37 Million TWD | -2.58% |
2012 Q4 | 697.35 Million TWD | 7.29% |
2012 Q1 | 643.54 Million TWD | 10.4% |
2012 Q2 | 641.71 Million TWD | -0.28% |
2012 FY | 697.35 Million TWD | 19.63% |
2012 Q3 | 649.94 Million TWD | 1.28% |
2011 Q3 | 605.53 Million TWD | -4.84% |
2011 Q4 | 582.91 Million TWD | -3.74% |
2011 Q1 | 461.99 Million TWD | -1.5% |
2011 Q2 | 636.34 Million TWD | 37.74% |
2011 FY | 582.91 Million TWD | 24.28% |
2010 FY | 469.04 Million TWD | 0.0% |
2010 Q4 | 469.04 Million TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Grape King Bio Ltd | 737.18 Million TWD | -116.698% |
Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | 1.084% |
Maywufa Company Ltd. | 257.91 Million TWD | -519.387% |
ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | -5.685% |
Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 57.687% |
LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -2526.592% |
YungShin Global Holding Corporation | 2.77 Billion TWD | 42.393% |
PhytoHealth Corporation | 163.09 Million TWD | -879.5% |
SCI Pharmtech, Inc. | 529.53 Million TWD | -201.675% |
PharmaEssentia Corporation | 1.45 Billion TWD | -9.517% |
Bora Pharmaceuticals Co., LTD. | 2.15 Billion TWD | 25.911% |